Unlocking the Microbial key to theFuture of humanHealth

SMALL
MICROBES.
MIGHTY
INNOVATIONS.

Our Process

4.
Launch

MADE
FOR
EVERY
STAGE
OF
THE
HEALTH
JOURNEY

We
ARE
ON
A
MISSION
TO
rapidly
innovate
and
deliver
breakthrough
solutions
for
unmet
medical
needs.

Pipeline
Launched
SBD111

SBD111

Clinically validated to slow bone loss via the targeting of osteoclastic activity (clinical study pending publication & peer review)

Toggle for Pipeline
July 2025

SBD121

Being developed to address the needs of rheumatoid arthritis

Toggle for Pipeline
December 2025

SBDXXX

Being developed to address the needs of psoriatic arthritis

Toggle for Pipeline
JUNE 2026

SBDXXX

Being developed to address the needs of cellular aging

Toggle for Pipeline

Recent
Company
News